FDA adds boxed warning to multiple sclerosis drugs

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...
Speaking about the incident, the mum said: “I was met with the most abusive woman who ridiculed me and my disability. “I ...
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...
Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.
The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...
The incidence of mental illness was higher among women with MS during both the prenatal period (incidence ratio [IR] 1.26, 95 ...